CRH plc (LON:CRH)

Achilles Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	49,185	50,085	37,468	23,853	30,073	24,663
Market Cap Growth	-1.50%	33.68%	57.08%	-20.68%	21.94%	3.40%
Enterprise Value	60,589	61,124	43,430	28,050	35,151	30,979
Last Close Price	73.56	73.57	52.83	30.90	35.41	27.10
PE Ratio	20.61	18.13	15.13	7.37	15.59	30.01
PS Ratio	1.85	1.76	1.37	0.88	1.39	1.30
PB Ratio	2.85	2.74	2.21	1.25	1.95	1.66
P/TBV Ratio	7.14	6.72	4.48	2.42	3.92	3.28
P/FCF Ratio	-	26.01	14.91	12.62	16.79	11.45
P/OCF Ratio	-	12.57	9.51	7.56	10.23	8.55
EV/Sales Ratio	2.22	2.15	1.58	1.03	1.63	1.63
EV/EBITDA Ratio	10.69	11.38	9.04	6.25	9.79	9.86
EV/EBIT Ratio	16.26	15.53	12.32	8.83	14.38	15.70
EV/FCF Ratio	37.96	31.74	17.29	14.84	19.63	14.38
Debt / Equity Ratio	0.78	0.68	0.61	0.48	0.58	0.68
Debt / EBITDA Ratio	2.34	2.11	1.92	1.82	2.50	3.23
Debt / FCF Ratio	7.45	6.46	4.11	4.81	5.02	4.71
Asset Turnover	0.73	0.73	0.75	0.73	0.65	0.56
Inventory Turnover	4.82	5.06	5.42	5.61	5.76	5.51
Quick Ratio	1.01	0.83	1.08	1.27	1.34	1.56
Current Ratio	1.64	1.37	1.69	1.85	1.85	2.01
Return on Equity (ROE)	15.35%	15.83%	13.76%	12.28%	12.15%	5.05%
Return on Assets (ROA)	6.24%	6.28%	6.05%	5.32%	4.62%	3.64%
Return on Capital (ROIC)	8.21%	8.42%	8.16%	7.13%	6.15%	4.72%
Return on Capital Employed (ROCE)	11.30%	12.20%	12.00%	10.30%	8.90%	7.20%
Earnings Yield	4.85%	5.57%	6.66%	13.44%	6.46%	3.33%
FCF Yield	3.25%	3.84%	6.71%	7.92%	5.96%	8.74%
Dividend Yield	1.53%	1.52%	1.98%	3.41%	2.52%	3.11%
Payout Ratio	29.51%	48.85%	29.58%	23.74%	34.45%	63.01%
Buyback Yield / Dilution	4.39%	5.44%	4.57%	2.89%	0.54%	2.05%
Total Shareholder Return	5.92%	6.96%	6.54%	6.30%	3.07%	5.16%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.